powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1134501224
Rania Farhat
M.D.
Pulmonary Disease
Saint Louis,
MO
I
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 140046
Hospital
CCN 260091
Hospital
CCN 260105
Hospital
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
68.5
Cost
72.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
235
Beneficiaries
—
Total drug cost
$75K
Distinct drugs
9
Brand share
80.0%
Top prescribed drugs
Albuterol Sulfate
67 claims
Tiotropium Bromide
41 claims
Fluticasone Propionate
31 claims
Fluticasone/Umeclidin/Vilanter
26 claims
Umeclidinium Brm/Vilanterol Tr
18 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$6K
Payment records
8
By payment type
Consulting Fee
$5K
Food and Beverage
$564
Travel and Lodging
$331
Top paying entities
Consulting Fee
$5K
Food and Beverage
$564
Travel and Lodging
$331
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
205
Unique beneficiaries
—
Total services
291
Distinct HCPCS
9
Medicare payment
$25K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 230 Pulmonary Disease providers in MO — bottom quintile (cohort median 922).
